| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 83735 |
|
478 |
407 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,387 |
2,109 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
426 |
418 |
$0.00 |
| 99443 |
|
568 |
553 |
$0.00 |
| 86780 |
|
65 |
65 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
2,076 |
1,833 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,577 |
2,549 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,372 |
1,337 |
$0.00 |
| 85027 |
|
880 |
783 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
6,584 |
5,472 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,992 |
1,852 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
227 |
222 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
373 |
369 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
282 |
280 |
$0.00 |
| 82043 |
|
838 |
822 |
$0.00 |
| 3074F |
|
277 |
250 |
$0.00 |
| 81001 |
|
242 |
228 |
$0.00 |
| 3075F |
|
68 |
66 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
461 |
459 |
$0.00 |
| 82746 |
|
27 |
25 |
$0.00 |
| 3044F |
|
155 |
154 |
$0.00 |
| 83550 |
|
160 |
157 |
$0.00 |
| 82728 |
|
86 |
85 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
117 |
115 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
41 |
40 |
$0.00 |
| 82607 |
|
111 |
109 |
$0.00 |
| 87340 |
|
122 |
122 |
$0.00 |
| 86141 |
|
12 |
12 |
$0.00 |
| 90686 |
|
77 |
77 |
$0.00 |
| 1111F |
|
75 |
71 |
$0.00 |
| 86706 |
|
125 |
125 |
$0.00 |
| 86592 |
|
32 |
32 |
$0.00 |
| 99441 |
|
17 |
15 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
17 |
12 |
$0.00 |
| 85652 |
|
26 |
25 |
$0.00 |
| 90656 |
|
14 |
14 |
$0.00 |
| 85610 |
|
431 |
343 |
$0.00 |
| 83540 |
|
175 |
172 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,920 |
3,190 |
$0.00 |
| 82540 |
|
838 |
822 |
$0.00 |
| 80061 |
Lipid panel |
1,920 |
1,905 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
97 |
97 |
$0.00 |
| 86703 |
|
559 |
559 |
$0.00 |
| 84100 |
|
27 |
25 |
$0.00 |
| 82570 |
|
113 |
105 |
$0.00 |
| 80076 |
|
237 |
235 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
226 |
216 |
$0.00 |
| 3078F |
|
369 |
335 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
67 |
36 |
$0.00 |
| 99442 |
|
395 |
385 |
$0.00 |
| 91300 |
|
140 |
140 |
$0.00 |
| 86480 |
|
163 |
159 |
$0.00 |
| 77062 |
|
71 |
71 |
$0.00 |
| 82565 |
|
15 |
15 |
$0.00 |
| 82274 |
|
147 |
146 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
41 |
40 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
116 |
114 |
$0.00 |
| 3077F |
|
54 |
53 |
$0.00 |